Skip to content

Clinical trials

Phase 3 Lupus Erythematosus, Systemic trials in Puerto Rico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Phase: Phase 3 Country / region: Puerto Rico Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20081
20102
20141
20151
20181
20212
20224
20234
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting6
Completed6
Enrolling by invitation3
Terminated3
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen2
Bristol-Myers Squibb2
Eli Lilly and Company2
ImmuPharma2
UCB Biopharma SRL2
Viatris Innovation GmbH2
AbbVie1
AstraZeneca1
Human Genome Sciences Inc.1
Human Genome Sciences Inc., a GSK Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic20
Autoimmune Diseases7
Connective Tissue Diseases6
Immune System Diseases6
Lupus Nephritis3
Nephritis1
Skin and Connective Tissue Diseases1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.